Letter to the Editor: Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels.

[1]  M. Buti,et al.  Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels. , 2022, Journal of hepatology.

[2]  X. Forns,et al.  Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: An international, multi-center, multi-ethnic cohort (RETRACT-B study). , 2021, Gastroenterology.

[3]  H. Janssen,et al.  Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatment , 2021, Alimentary pharmacology & therapeutics.

[4]  J. Niu,et al.  Combining HBV RNA and hepatitis B core-related antigen: guidance for safely stopping nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B patients. , 2020, The Journal of infectious diseases.

[5]  Q. Ning,et al.  Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  Haitao Guo,et al.  Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection , 2019, Hepatology.

[7]  Y. Liaw,et al.  Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen–negative chronic hepatitis B , 2018, Hepatology.

[8]  T. Berg,et al.  Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study. , 2017, Journal of hepatology.

[9]  E. Cholongitas,et al.  Discontinuation of oral antivirals in chronic hepatitis B: A systematic review , 2016, Hepatology.

[10]  H. Janssen,et al.  Reduced risk of relapse after long‐term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B , 2015, Alimentary pharmacology & therapeutics.